Retraction Note: A prospective, double-blind, randomized, placebo-controlled clinical trial of bromocriptin in clomiphene-resistant patients with polycystic ovary syndrome and normal prolactin level
Crossref DOI link: https://doi.org/10.1007/s00404-023-07330-z
Published Online: 2023-12-23
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Parsanezhad, Mohammad Ebrahim
Alborzi, Saeed
Namavar Jahromi, Bahia
Text and Data Mining valid from 2023-12-23
Version of Record valid from 2023-12-23
Article History
First Online: 23 December 2023
Free to read: This content has been made available to all.